Healthcare · Pharmaceutical expenditure
Pharmaceutical expenditure in Cameroon accounts for 0.90 % GDP of GDP in 2026, ranking 123rd out of 197 countries. This low share reflects the reliance of many Cameroonians on traditional medicine and the underdeveloped market for modern drugs, constrained by high import dependency and limited purchasing power. Most public spending is directed toward essential medicines for malaria, HIV, and tuberculosis — the country's primary health burdens.
Data for 2026 · unit: % GDP
Position
#123 / 197
Cameroon world ranking
Country position on the scale from last to first place for this indicator.
CM
#123
#197#1
Trend
Change over time
Change in indicator over the available period.
0.60
1990
0.90
2000
1.10
2010
1.40
2020
0.90
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Cameroon stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Cameroon — how much?
Based on 2026 data — 0.90 % GDP. This is rank #123 out of 197 countries.
What is Cameroon's rank by Pharmaceutical expenditure?
Cameroon ranks #123 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Cameroon?
Over the available period the indicator changed from 0.60 to 0.90 % GDP.